Trastuzumab Tied to Higher Long-Term Risk for Heart Failure
WEDNESDAY, March 20, 2019 -- Compared with chemotherapy alone, trastuzumab is associated with a twofold increased long-term risk for heart failure in breast cancer survivors, according to a study published in the March 1 issue of JACC: Heart...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Chemotherapy | Heart | Heart Failure | Herceptin | Pharmaceuticals | Study